Approval · Notice of Compliance 7277 · 2005
PRIMAXIN: Notice of Compliance 7277
Issued August 8, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7277
- Date
- August 8, 2005
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PRIMAXIN | 00717274 | Cancelled Post Market |
| PRIMAXIN | 00717282 | Cancelled Post Market |
| PRIMAXIN IV | 01911449 | Cancelled Post Market |
Medicinal ingredients
- IMIPENEM 250 MG per VIAL
- CILASTATIN SODIUM 250 MG per VIAL
- IMIPENEM 500 MG per VIAL
- CILASTATIN SODIUM 500 MG per VIAL